Horizon Pharma reported $51.95M in Trade Creditors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Adamas Pharmaceuticals ADMS:US 2.47M 304K
Aerie Pharmaceuticals AERI:US $ 7.44M 0.92M
Amgen AMGN:US $ 1277M 119M
Antares Pharma ATRS:US $ 15.8M 0.97M
Bristol Myers Squibb BMY:US $ 3609M 637M
Cara Therapeutics CARA:US $ 3.39M 1.38M
Coherus Biosciences CHRS:US $ 14.57M 0.91M
Eli Lilly And LLY:US $ 1597.8M 41.8M
Endo International Ordinary Shares ENDP:US $ 103.84M 0.68M
Flexion Therapeutics FLXN:US $ 5.47M 1.18M
Horizon Pharma HZNP:US $ 51.95M 8.96M
JAZZ PHA JAZZ:US $ 64.83M 12.91M
Novartis NOVN:VX 4.81B 229M
Pacira Pharmaceuticals PCRX:US $ 12.18M 3.07M
Perrigo Ordinary Shares PRGO:US $ 402.4M 27.9M
Prestige Brands PBH:US $ 30.96M 15.02M
Revance Therapeutics RVNC:US $ 8.18M 1.1M
Takeda 4502:JP Y 320645M 23193M
Teva Pharmaceutical Industries TEVA:US $ 1551M 141M
Valeant Pharmaceuticals VRX:CN $ 442M 100M
Xeris Pharmaceuticals Inc XERS:US $ 5.18M 417K
Zoetis ZTS:US $ 369M 23M